Bio-Rad Reports First-Quarter 2026 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Bio-Rad Reports First-Quarter 2026 Financial Results

Bio-Rad Labs (BIO) Tops Q1 EPS by 5c, Beats on Revenue; Offers Guidance

April 30, 2026 4:24 PM EDT

Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $1.89, $0.05 better than the analyst estimate of $1.84. Revenue for the quarter came in at $592.1 million versus the consensus estimate of $586.97 million.

Bio-Rad is updating its financial outlook for the full-year 2026. The Company currently expects non-GAAP,... More